nVerses Capital LLC Purchases 400 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

nVerses Capital LLC increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 200.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 600 shares of the company’s stock after acquiring an additional 400 shares during the period. nVerses Capital LLC’s holdings in Prestige Consumer Healthcare were worth $43,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Opal Wealth Advisors LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter valued at about $26,000. Quest Partners LLC increased its holdings in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares during the period. Gladius Capital Management LP bought a new position in Prestige Consumer Healthcare in the second quarter worth approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after acquiring an additional 433 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.6 %

Shares of Prestige Consumer Healthcare stock opened at $71.74 on Wednesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The company has a fifty day moving average of $71.55 and a 200 day moving average of $69.31. The company has a market capitalization of $3.56 billion, a P/E ratio of 17.54, a P/E/G ratio of 2.05 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter last year, the company earned $1.06 EPS. The firm’s quarterly revenue was down 4.4% on a year-over-year basis. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

PBH has been the subject of several analyst reports. DA Davidson upped their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.